Acquired von Willebrand syndrome

被引:0
|
作者
Arabi, Abdessamad [1 ]
Taouli, Katia [2 ]
Chaffa, Ouardia [3 ]
Bekadja, Mohammad Amine [1 ]
机构
[1] Etablissement Hosp Univ 1Er Novembre 1954, Serv Hematol & Therapie Cellulaire, Ehu Oran, Algeria
[2] Ctr Hosp Univ, Serv Hemobiol, Tilimsen, Algeria
[3] Ctr Hosp Univ Mustapha, Serv Hemobiol, Algiers, Algeria
来源
SANG THROMBOSE VAISSEAUX | 2011年 / 23卷 / 06期
关键词
aquired von Willebrand syndrome; lymphoproliferative disorder and autoimmune disease; diagnosis; treatment;
D O I
10.1684/stv.2011.0614
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Acquired von Willebrand syndrome Acquired von Willebrand syndrome is rare disease, with clinical and biological features strikingly similar to the congenital form. 300 cases were reported in the literature. Most often, it occurs in old patients, ant it is frequently associated with autoimmune or lymphoproliferative disorders. Diagnosis is not difficult. According to literature, substitutive treatment is not efficient in all cases; etiologic treatment seems the better solution. Physiopathology is unknown. This is a case report of Acquired von Willebrand Syndrome diagnosed in a 62 old year man, without associated pathology.
引用
收藏
页码:303 / 306
页数:4
相关论文
共 50 条
  • [41] Evaluation of the Utility of von Willebrand Factor Propeptide in the Differential Diagnosis of von Willebrand Disease and Acquired von Willebrand Syndrome
    Stufano, Francesca
    Boscarino, Marco
    Bucciarelli, Paolo
    Baronciani, Luciano
    Maino, Alberto
    Cozzi, Giovanna
    Peyvandi, Flora
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2019, 45 (01): : 36 - 42
  • [42] THE VON-WILLEBRAND-FACTOR PROPOLYPEPTIDE (VWAGII) AS A MARKER OF ACQUIRED VON-WILLEBRAND SYNDROME
    SCOTT, JP
    VOKAC, E
    FOSTER, PA
    KASAY, K
    MONTGOMERY, RR
    BLOOD, 1993, 82 (10) : A150 - A150
  • [43] More to Learn About Acquired Von Willebrand Syndrome
    McMichael, Ali B. V.
    Fan, Eddy
    Annich, Gail M.
    ASAIO JOURNAL, 2023, 69 (01) : E53 - E53
  • [44] Acquired von Willebrand syndrome in systemic lupus erythematodes
    Michiels, JJ
    Schroyens, W
    van der Planken, M
    Berneman, Z
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2001, 7 (02) : 106 - 112
  • [46] Acquired Von Willebrand syndrome: about one observation
    Messaoudi, R.
    Hadj, T.
    Benlaledj, D.
    Rahal, Y.
    Cherif-Hosni, A.
    Bensahli, M.
    Bekadja, M. A.
    Arabi, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 1027 - 1027
  • [47] Treatment of acquired autoimmune Von Willebrand syndrome with bortezomib
    Schuler, U.
    Tiebel, O.
    Trautmann, K.
    Alakel, N.
    Thiel, T.
    Hoelig, K.
    Roellig, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 323 - 323
  • [48] Acquired von Willebrand syndrome: from pathophysiology to management
    Veyradier, A
    Jenkins, CSP
    Fressinaud, E
    Meyer, D
    THROMBOSIS AND HAEMOSTASIS, 2000, 84 (02) : 175 - 182
  • [49] Acquired von Willebrand syndrome in patients with Gaucher disease
    Mitrovic, Mirjana
    Elezovic, Ivo
    Miljic, Predrag
    Suvajdzic, Nada
    BLOOD CELLS MOLECULES AND DISEASES, 2014, 52 (04) : 205 - 207
  • [50] How I treat the acquired von Willebrand syndrome
    Tiede, Andreas
    Rand, Jacob H.
    Budde, Ulrich
    Ganser, Arnold
    Federici, Augusto B.
    BLOOD, 2011, 117 (25) : 6777 - 6785